SOLID TUMOURS:@0.084848:0.038601:0.266058:0.038601:0.266058:0.019343:0.084848:0.019343:0.011712:0.020438:0.010866:0.005315:0.017498:0.006515:0.010019:0.015405:0.021613:0.020438:0.015405:0.014276:0.011712
32:@0.023705:0.038809:0.044778:0.038809:0.044778:0.019212:0.023705:0.019212:0.010536:0.010536
HANDBOOK OF ONCOLOGY:@0.084848:0.970015:0.320957:0.970015:0.320957:0.956010:0.084848:0.956010:0.011682:0.012657:0.012657:0.012726:0.009818:0.014864:0.014864:0.010109:0.004738:0.014864:0.008296:0.004738:0.014864:0.012657:0.013906:0.014864:0.007902:0.014864:0.014915:0.010126
Dr S Dalvie:@0.084242:0.144082:0.183148:0.144082:0.183148:0.128049:0.084242:0.128049:0.013470:0.006158:0.005388:0.010006:0.005388:0.013470:0.012700:0.004618:0.010776:0.004618:0.012315
MBCHB, FC(RadOnc):@0.084242:0.160579:0.278206:0.160579:0.278206:0.144360:0.084242:0.144360:0.017318:0.011161:0.015009:0.013085:0.011161:0.005388:0.005388:0.009236:0.015009:0.007312:0.011161:0.012700:0.012700:0.016164:0.011545:0.012315:0.007312
 :@0.084242:0.176957:0.120630:0.176957:0.120630:0.162272:0.084242:0.162272:0.017145:0.019242
Specialist, Departments of Radiation :@0.120630:0.177076:0.463664:0.177076:0.463664:0.161320:0.120630:0.161320:0.009583:0.013123:0.012508:0.012450:0.003848:0.013143:0.003848:0.003848:0.007466:0.006523:0.005330:0.005330:0.014316:0.012508:0.013123:0.013143:0.005792:0.006523:0.018049:0.012508:0.011738:0.006523:0.007466:0.005330:0.012604:0.006042:0.005330:0.011680:0.013143:0.013181:0.003848:0.013143:0.006523:0.003848:0.012604:0.011738:0.005330
Medicine and Radiation Oncology, :@0.084242:0.193573:0.419657:0.193573:0.419657:0.177817:0.084242:0.177817:0.017684:0.012508:0.013181:0.003848:0.012450:0.003848:0.011738:0.012508:0.005330:0.013143:0.011738:0.013181:0.005330:0.011680:0.013143:0.013181:0.003848:0.013143:0.006523:0.003848:0.012604:0.011738:0.005330:0.016722:0.011738:0.012450:0.012604:0.003848:0.012604:0.012950:0.010314:0.005330:0.005330
Groote Schuur Hospital and University of :@0.084242:0.210083:0.461623:0.210083:0.461623:0.194327:0.084242:0.194327:0.016779:0.005713:0.012604:0.012604:0.006523:0.012508:0.005330:0.009583:0.012450:0.011738:0.011699:0.011699:0.005792:0.005330:0.013143:0.012604:0.007466:0.013123:0.003848:0.006523:0.013143:0.003848:0.005330:0.013143:0.011738:0.013181:0.005330:0.012604:0.011738:0.003848:0.010660:0.012508:0.005792:0.007466:0.003848:0.006523:0.010314:0.005330:0.012604:0.006042:0.005330
Cape Town, Department of Radiation :@0.084242:0.226579:0.440802:0.226579:0.440802:0.210824:0.084242:0.210824:0.015644:0.013143:0.013123:0.012508:0.005330:0.007252:0.012604:0.015990:0.011738:0.005330:0.005330:0.014316:0.012508:0.013123:0.013143:0.005792:0.006523:0.018049:0.012508:0.011738:0.006523:0.005330:0.012604:0.006042:0.005330:0.011680:0.013143:0.013181:0.003848:0.013143:0.006523:0.003848:0.012604:0.011738:0.005330
Oncology, Groote Schuur Hospital:@0.084242:0.243076:0.402173:0.243076:0.402173:0.227320:0.084242:0.227320:0.016722:0.011738:0.012450:0.012604:0.003848:0.012604:0.012950:0.010314:0.005330:0.005330:0.016779:0.005703:0.012604:0.012604:0.006523:0.012508:0.005330:0.009583:0.012450:0.011738:0.011699:0.011699:0.005792:0.005330:0.013143:0.012604:0.007466:0.013123:0.003848:0.006523:0.013143:0.003848
Carcinoma of the  lung is responsible for :@0.084242:0.276083:0.480490:0.276083:0.480490:0.260327:0.084242:0.260327:0.015644:0.013143:0.005657:0.012450:0.003848:0.011738:0.012604:0.018049:0.013143:0.009217:0.012604:0.006042:0.009217:0.006523:0.011738:0.012508:0.005330:0.003877:0.003848:0.011699:0.011738:0.012950:0.009217:0.003848:0.007466:0.009217:0.005713:0.012508:0.007466:0.013123:0.012604:0.011738:0.007466:0.003848:0.013123:0.003848:0.012508:0.009217:0.006042:0.012604:0.005792:0.005330
more deaths than any other cancer. Lung :@0.084242:0.292580:0.480517:0.292580:0.480517:0.276824:0.084242:0.276824:0.018049:0.012604:0.005709:0.012508:0.005455:0.013181:0.012508:0.013143:0.006523:0.011738:0.007466:0.005465:0.006523:0.011738:0.013143:0.011738:0.005465:0.013143:0.011738:0.010314:0.005465:0.012604:0.006523:0.011738:0.012508:0.005792:0.005442:0.012450:0.013143:0.011738:0.012450:0.012508:0.004374:0.005330:0.005455:0.008890:0.011699:0.011738:0.012950:0.005330
cancer is the cause of death of approxi-:@0.084242:0.309077:0.475158:0.309077:0.475158:0.293321:0.084242:0.293321:0.012450:0.013143:0.011738:0.012450:0.012508:0.005792:0.007410:0.003848:0.007466:0.007428:0.006523:0.011738:0.012508:0.007410:0.012450:0.013143:0.011699:0.007466:0.012508:0.007428:0.012604:0.006042:0.007412:0.013181:0.012508:0.013143:0.006523:0.011738:0.007416:0.012604:0.006042:0.007414:0.013143:0.013123:0.013123:0.005719:0.012604:0.009236:0.003848:0.006388
mately 18% of all cancer patients. The :@0.084242:0.325573:0.480482:0.325573:0.480482:0.309817:0.084242:0.309817:0.018049:0.013143:0.006523:0.012508:0.003848:0.010314:0.011680:0.010660:0.010660:0.014913:0.011680:0.012604:0.006042:0.011680:0.013143:0.003848:0.003848:0.011680:0.012450:0.013143:0.011738:0.012450:0.012508:0.005792:0.011680:0.013123:0.013143:0.006523:0.003848:0.012508:0.011738:0.006523:0.007466:0.005330:0.011680:0.008197:0.011738:0.012508:0.005330
global incidence rates mirror the smoking :@0.084242:0.342070:0.480478:0.342070:0.480478:0.326314:0.084242:0.326314:0.012950:0.003848:0.012604:0.013123:0.013143:0.003848:0.006562:0.003848:0.011738:0.012450:0.003848:0.013181:0.012508:0.011738:0.012450:0.012508:0.006562:0.005792:0.013143:0.006523:0.012508:0.007466:0.006562:0.018049:0.003848:0.005792:0.005711:0.012604:0.005792:0.006562:0.006523:0.011738:0.012508:0.006562:0.007466:0.018049:0.012604:0.009660:0.003848:0.011738:0.012950:0.005330
prevalence  rates.  The  estimated  overall :@0.084242:0.358567:0.480476:0.358567:0.480476:0.342811:0.084242:0.342811:0.013123:0.005715:0.012508:0.010660:0.013143:0.003848:0.012508:0.011738:0.012450:0.012508:0.005330:0.005511:0.005792:0.013143:0.006523:0.012508:0.007466:0.005330:0.005330:0.005507:0.008197:0.011738:0.012508:0.005330:0.005501:0.012508:0.007466:0.006523:0.003848:0.018049:0.013143:0.006523:0.012508:0.013181:0.005330:0.005507:0.012604:0.010660:0.012508:0.005792:0.013143:0.003848:0.003848:0.005330
incidence rate for southern Africa is 189.6 :@0.084242:0.375064:0.480486:0.375064:0.480486:0.359308:0.084242:0.359308:0.003848:0.011738:0.012450:0.003848:0.013181:0.012508:0.011738:0.012450:0.012508:0.006504:0.005792:0.013143:0.006523:0.012508:0.006490:0.006042:0.012604:0.005792:0.006489:0.007466:0.012604:0.011699:0.006523:0.011738:0.012508:0.006181:0.011738:0.006494:0.014239:0.006042:0.005792:0.003848:0.012450:0.013143:0.006504:0.003848:0.007466:0.006504:0.010660:0.010660:0.010660:0.005330:0.010660:0.005330
per 100 000  population.  The estimated :@0.084242:0.391560:0.480476:0.391633:0.480476:0.375877:0.084242:0.375804:0.013123:0.012508:0.005792:0.011103:0.010660:0.010660:0.010672:0.011103:0.010660:0.010660:0.010660:0.005330:0.005786:0.013123:0.012604:0.013123:0.011699:0.003848:0.013143:0.006523:0.003848:0.012604:0.011738:0.005330:0.006213:0.011103:0.008197:0.011738:0.012498:0.011103:0.012508:0.007466:0.006523:0.003848:0.018049:0.013143:0.006523:0.012508:0.013181:0.432669
1:@0.320541:0.386014:0.326755:0.386014:0.326755:0.376828:0.320541:0.376828:0.006215
overall mortality rate for southern Africa is :@0.084246:0.408130:0.480503:0.408130:0.480503:0.392374:0.084246:0.392374:0.012604:0.010660:0.012508:0.005792:0.013143:0.003848:0.003848:0.006369:0.018049:0.012604:0.005792:0.006523:0.013143:0.003848:0.003848:0.006523:0.010314:0.006369:0.005792:0.013143:0.006523:0.012508:0.006358:0.006042:0.012604:0.005792:0.006356:0.007466:0.012604:0.011699:0.006523:0.011738:0.012508:0.006190:0.011738:0.006369:0.014239:0.006042:0.005792:0.003848:0.012450:0.013143:0.006360:0.003848:0.007466:0.005330
133.2 per 100 000 population.:@0.084246:0.424626:0.356506:0.424626:0.356506:0.408870:0.084246:0.408870:0.010660:0.010660:0.010660:0.005330:0.010660:0.005330:0.013123:0.012508:0.005792:0.005330:0.010660:0.010660:0.010660:0.005330:0.010660:0.010660:0.010660:0.005330:0.013123:0.012604:0.013123:0.011699:0.003848:0.013143:0.006523:0.003848:0.012604:0.011738:0.005330
1:@0.356521:0.419021:0.362735:0.419021:0.362735:0.409835:0.356521:0.409835:0.006215
Early stages of the disease are potentially :@0.102424:0.441143:0.480472:0.441143:0.480472:0.425387:0.102424:0.425387:0.010314:0.013143:0.005792:0.003848:0.010314:0.003387:0.007466:0.006523:0.013143:0.012950:0.012508:0.007466:0.003387:0.012604:0.006042:0.003387:0.006523:0.011738:0.012508:0.003387:0.013181:0.003848:0.007466:0.012508:0.013143:0.007466:0.012508:0.003400:0.013143:0.005713:0.012508:0.003387:0.013123:0.012604:0.006523:0.012508:0.011738:0.006523:0.003848:0.013143:0.003848:0.003848:0.010314:0.005330
curable, but most patients are diagnosed :@0.084240:0.457640:0.480489:0.457640:0.480489:0.441884:0.084240:0.441884:0.012450:0.011699:0.005792:0.013143:0.013123:0.003848:0.012508:0.005330:0.006032:0.013123:0.011699:0.006523:0.006042:0.018049:0.012604:0.007466:0.006523:0.006032:0.013123:0.013143:0.006523:0.003848:0.012508:0.011738:0.006523:0.007466:0.006042:0.013143:0.005715:0.012508:0.006032:0.013181:0.003848:0.013143:0.012950:0.011738:0.012604:0.007466:0.012508:0.013181:0.005330
with  advanced  disease. A  contributing :@0.084240:0.474137:0.480495:0.474137:0.480495:0.458381:0.084240:0.458381:0.015990:0.003848:0.006523:0.011738:0.005330:0.007241:0.013143:0.013181:0.010660:0.013143:0.011738:0.012450:0.012508:0.013181:0.005330:0.007243:0.013181:0.003848:0.007466:0.012508:0.013143:0.007466:0.012508:0.005330:0.012585:0.014239:0.005330:0.007237:0.012450:0.012604:0.011738:0.006523:0.005792:0.003848:0.013123:0.011699:0.006523:0.003848:0.011738:0.012950:0.005330
factor  is  the  non-specifi city  of  presenting :@0.084240:0.490633:0.480485:0.490633:0.480485:0.474877:0.084240:0.474877:0.006042:0.013143:0.012450:0.006523:0.012604:0.005792:0.005330:0.002892:0.003848:0.007466:0.005330:0.002906:0.006523:0.011738:0.012508:0.005330:0.002896:0.011738:0.012604:0.011738:0.006388:0.007466:0.013123:0.012508:0.012450:0.003848:0.004686:0.000000:0.004684:0.012450:0.003848:0.006523:0.010314:0.005330:0.002906:0.012604:0.006042:0.005330:0.002902:0.013123:0.005715:0.012508:0.007466:0.012508:0.011738:0.006523:0.003848:0.011738:0.012950:0.005330
symptoms, resulting in a delay in diagnosis. :@0.084240:0.507130:0.480458:0.507130:0.480458:0.491374:0.084240:0.491374:0.007466:0.010314:0.018049:0.013123:0.006523:0.012604:0.018049:0.007466:0.005330:0.004464:0.005713:0.012508:0.007466:0.011699:0.003848:0.006523:0.003848:0.011738:0.012950:0.004464:0.003848:0.011738:0.004464:0.013143:0.004464:0.013181:0.012508:0.003848:0.013143:0.010314:0.004464:0.003848:0.011738:0.004464:0.013181:0.003848:0.013143:0.012950:0.011738:0.012604:0.007466:0.003848:0.007466:0.005330:0.005330
Additionally, symptoms may only be expe-:@0.084240:0.523627:0.475111:0.523627:0.475111:0.507871:0.084240:0.507871:0.014239:0.013181:0.013181:0.003848:0.006523:0.003848:0.012604:0.011738:0.013143:0.003848:0.003848:0.010314:0.005330:0.004445:0.007466:0.010314:0.018049:0.013123:0.006523:0.012604:0.018049:0.007466:0.004445:0.018049:0.013143:0.010314:0.004445:0.012604:0.011738:0.003848:0.010314:0.004445:0.013123:0.012508:0.004445:0.012508:0.009236:0.013123:0.012508:0.006388
rienced at an advanced stage of disease. :@0.084240:0.540124:0.480476:0.540124:0.480476:0.524368:0.084240:0.524368:0.005792:0.003848:0.012508:0.011738:0.012450:0.012508:0.013181:0.004603:0.013143:0.006523:0.004609:0.013143:0.011738:0.004607:0.013143:0.013181:0.010660:0.013143:0.011738:0.012450:0.012508:0.013181:0.004618:0.007466:0.006523:0.013143:0.012950:0.012508:0.004607:0.012604:0.006042:0.004605:0.013181:0.003848:0.007466:0.012508:0.013143:0.007466:0.012508:0.005330:0.005330
Further  factors are the high prevalence :@0.084240:0.556620:0.480485:0.556620:0.480485:0.540864:0.084240:0.540864:0.009333:0.011699:0.005792:0.006523:0.011738:0.012508:0.005792:0.005330:0.005238:0.006042:0.013143:0.012450:0.006523:0.012604:0.005792:0.007466:0.010583:0.013143:0.005715:0.012508:0.010583:0.006523:0.011738:0.012508:0.010583:0.011738:0.003848:0.012950:0.011738:0.010583:0.013123:0.005717:0.012508:0.010660:0.013143:0.003848:0.012508:0.011738:0.012450:0.012508:0.005330
and incidence rates of tuberculosis (TB) in :@0.084240:0.573117:0.480485:0.573117:0.480485:0.557361:0.084240:0.557361:0.013143:0.011738:0.013181:0.006100:0.003848:0.011738:0.012450:0.003848:0.013181:0.012508:0.011738:0.012450:0.012508:0.006100:0.005792:0.013143:0.006523:0.012508:0.007466:0.006100:0.012604:0.006042:0.006090:0.006523:0.011699:0.013123:0.012508:0.005653:0.012450:0.011699:0.003848:0.012604:0.007466:0.003848:0.007466:0.006100:0.007100:0.008197:0.011045:0.007100:0.006100:0.003848:0.011738:0.005330
South Africa.:@0.084240:0.589614:0.202562:0.589614:0.202562:0.573858:0.084240:0.573858:0.009583:0.012604:0.011699:0.006523:0.011738:0.005330:0.014239:0.006042:0.005792:0.003848:0.012450:0.013143:0.005330
The most signifi cant factor in the aetiolo-:@0.102424:0.606124:0.475178:0.606124:0.475178:0.590368:0.102424:0.590368:0.008005:0.011545:0.012315:0.005827:0.017857:0.012411:0.007274:0.006331:0.005827:0.007274:0.003656:0.012758:0.011545:0.003656:0.004589:0.000000:0.004587:0.012257:0.012950:0.011545:0.006331:0.005825:0.005850:0.012950:0.012257:0.006331:0.012411:0.005600:0.005827:0.003656:0.011545:0.005827:0.006331:0.011545:0.012315:0.005827:0.012950:0.012315:0.006331:0.003656:0.012411:0.003656:0.012411:0.006388
gy of lung cancer is smoking. Cancer of the :@0.084240:0.622621:0.480509:0.622621:0.480509:0.606865:0.084240:0.606865:0.012758:0.010122:0.004201:0.012411:0.005850:0.004201:0.003656:0.011507:0.011545:0.012758:0.004201:0.012257:0.012950:0.011545:0.012257:0.012315:0.005600:0.004201:0.003656:0.007274:0.004203:0.007274:0.017857:0.012411:0.009467:0.003656:0.011545:0.012758:0.005138:0.004201:0.015452:0.012950:0.011545:0.012257:0.012315:0.005600:0.004203:0.012411:0.005850:0.004201:0.006331:0.011545:0.012506:0.005330
lung can be related to smoking (present or :@0.084240:0.639117:0.480530:0.639117:0.480530:0.623362:0.084240:0.623362:0.003656:0.011507:0.011545:0.012758:0.005195:0.012257:0.012950:0.011545:0.005195:0.012931:0.012315:0.005195:0.005521:0.012315:0.003656:0.012950:0.006331:0.012315:0.012989:0.005195:0.006331:0.012411:0.005195:0.007274:0.017857:0.012411:0.009467:0.003656:0.011545:0.012758:0.005195:0.006908:0.012931:0.005521:0.012315:0.007274:0.012315:0.011545:0.006331:0.005195:0.012411:0.005788:0.005330
past) in 85% of cases. In 5% of cases, cancer :@0.084240:0.655614:0.480468:0.655614:0.480468:0.639858:0.084240:0.639858:0.012931:0.012950:0.007274:0.006331:0.006908:0.003856:0.003656:0.011545:0.003856:0.010468:0.010468:0.014720:0.003856:0.012411:0.005850:0.003856:0.012257:0.012950:0.007274:0.012315:0.007274:0.005138:0.003856:0.004156:0.011545:0.003856:0.010468:0.014720:0.003856:0.012411:0.005850:0.003856:0.012257:0.012950:0.007274:0.012315:0.007274:0.005138:0.003856:0.012257:0.012950:0.011545:0.012257:0.012315:0.005788:0.005330
of the lung can be related to passive smok-:@0.084240:0.672111:0.475109:0.672111:0.475109:0.656355:0.084240:0.656355:0.012411:0.005850:0.004483:0.006331:0.011545:0.012315:0.004483:0.003656:0.011507:0.011545:0.012758:0.004483:0.012257:0.012950:0.011545:0.004483:0.012931:0.012315:0.004483:0.005521:0.012315:0.003656:0.012950:0.006331:0.012315:0.012989:0.004483:0.006331:0.012411:0.004483:0.012931:0.012950:0.007274:0.007274:0.003656:0.010468:0.012315:0.004483:0.007274:0.017857:0.012411:0.009467:0.006388
ing, i.e., exposure to others who smoke. As-:@0.084240:0.688608:0.475225:0.688608:0.475225:0.672852:0.084240:0.672852:0.003656:0.011545:0.012758:0.005138:0.005292:0.003656:0.005138:0.012315:0.005138:0.005138:0.005292:0.012315:0.009044:0.012931:0.012411:0.007274:0.011507:0.005521:0.012315:0.005292:0.006331:0.012411:0.005292:0.012411:0.006331:0.011545:0.012315:0.005600:0.007274:0.005292:0.015798:0.011545:0.012411:0.005292:0.007274:0.017857:0.012411:0.009467:0.012315:0.005138:0.005292:0.014047:0.007274:0.006388
bestos or radon exposure may also cause :@0.084240:0.705105:0.480483:0.705105:0.480483:0.689349:0.084240:0.689349:0.012931:0.012315:0.007274:0.006331:0.012411:0.007274:0.006973:0.012411:0.005600:0.006973:0.005600:0.012950:0.012989:0.012411:0.011545:0.006973:0.012315:0.009044:0.012931:0.012411:0.007274:0.011507:0.005519:0.012315:0.006973:0.017857:0.012950:0.010122:0.006975:0.012950:0.003656:0.007274:0.012411:0.006973:0.012257:0.012950:0.011507:0.007274:0.012506:0.005330
lung cancer. Lung cancers may also de-:@0.084240:0.721601:0.475198:0.721601:0.475198:0.705845:0.084240:0.705845:0.003656:0.011507:0.011545:0.012758:0.008871:0.012257:0.012950:0.011545:0.012257:0.012315:0.004185:0.005138:0.008871:0.008698:0.011507:0.011545:0.012758:0.008871:0.012257:0.012950:0.011545:0.012257:0.012315:0.005600:0.007274:0.008871:0.017857:0.012950:0.010122:0.008871:0.012950:0.003656:0.007274:0.012411:0.008871:0.012989:0.012315:0.006388
velop secondary to radiation therapy to :@0.084240:0.738098:0.480495:0.738098:0.480495:0.722342:0.084240:0.722342:0.010468:0.012315:0.003656:0.012411:0.012931:0.010025:0.007274:0.012315:0.012257:0.012411:0.011545:0.012989:0.012950:0.005600:0.010122:0.010025:0.006331:0.012411:0.010025:0.005600:0.012950:0.012989:0.003656:0.012950:0.006331:0.003656:0.012411:0.011545:0.010025:0.006331:0.011545:0.012315:0.005600:0.012950:0.012931:0.010122:0.010025:0.006331:0.012600:0.005330
the chest, for example in lymphoma and :@0.084240:0.754595:0.480482:0.754595:0.480482:0.738839:0.084240:0.738839:0.006331:0.011545:0.012315:0.008120:0.012257:0.011545:0.012315:0.007274:0.006331:0.005138:0.008120:0.005850:0.012411:0.005600:0.008120:0.012315:0.009044:0.012950:0.017857:0.012931:0.003656:0.012315:0.008120:0.003656:0.011545:0.008120:0.003656:0.010122:0.017857:0.012931:0.011545:0.012411:0.017857:0.012950:0.008120:0.012950:0.011545:0.013183:0.005330
breast-cancer survivors. Epidemiological :@0.084240:0.771092:0.480482:0.771092:0.480482:0.755336:0.084240:0.755336:0.012931:0.005521:0.012315:0.012950:0.007274:0.006331:0.006196:0.012257:0.012950:0.011545:0.012257:0.012315:0.005600:0.016799:0.007274:0.011507:0.005600:0.010468:0.003656:0.010468:0.012411:0.005600:0.007274:0.005138:0.016799:0.010122:0.012931:0.003656:0.012989:0.012315:0.017857:0.003656:0.012411:0.003656:0.012411:0.012758:0.003656:0.012257:0.012950:0.003852:0.005330
studies document an increased incidence :@0.084240:0.787588:0.480493:0.787588:0.480493:0.771832:0.084240:0.771832:0.007274:0.006331:0.011507:0.012989:0.003656:0.012315:0.007274:0.006081:0.012989:0.012411:0.012257:0.011507:0.017857:0.012315:0.011545:0.006331:0.006081:0.012950:0.011545:0.006081:0.003656:0.011545:0.012257:0.005519:0.012315:0.012950:0.007274:0.012315:0.012989:0.006081:0.003656:0.011545:0.012257:0.003656:0.012989:0.012315:0.011545:0.012257:0.012506:0.005330
of lung cancer in patients who have been :@0.084240:0.804085:0.480499:0.804085:0.480499:0.788329:0.084240:0.788329:0.012411:0.005850:0.005917:0.003656:0.011507:0.011545:0.012758:0.005915:0.012257:0.012950:0.011545:0.012257:0.012315:0.005600:0.005915:0.003656:0.011545:0.005917:0.012931:0.012950:0.006331:0.003656:0.012315:0.011545:0.006331:0.007274:0.005917:0.015798:0.011545:0.012411:0.005915:0.011545:0.012950:0.010468:0.012315:0.005917:0.012931:0.012315:0.012315:0.011734:0.005330
previously diagnosed with tuberculosis (TB). :@0.084240:0.820582:0.480472:0.820582:0.480472:0.804826:0.084240:0.804826:0.012931:0.005521:0.012315:0.010468:0.003656:0.012411:0.011507:0.007274:0.003656:0.010122:0.005061:0.012989:0.003656:0.012950:0.012758:0.011545:0.012411:0.007274:0.012315:0.012989:0.005061:0.015798:0.003656:0.006331:0.011545:0.005061:0.006331:0.011507:0.012931:0.012315:0.005463:0.012257:0.011507:0.003656:0.012411:0.007274:0.003656:0.007274:0.005061:0.006908:0.008005:0.010853:0.006908:0.005326:0.005330
Non-smokers most frequently develop ad-:@0.084240:0.837079:0.475186:0.837079:0.475186:0.821323:0.084240:0.821323:0.014047:0.012411:0.011545:0.006196:0.007274:0.017857:0.012411:0.009467:0.012315:0.005600:0.007274:0.007293:0.017857:0.012411:0.007274:0.006331:0.007293:0.005850:0.005521:0.012315:0.012931:0.011507:0.012315:0.011545:0.006331:0.003656:0.010122:0.007293:0.012989:0.012315:0.010468:0.012315:0.003656:0.012411:0.012931:0.007293:0.012950:0.012989:0.006388
enocarcinoma.:@0.084240:0.853575:0.227190:0.853575:0.227190:0.837820:0.084240:0.837820:0.012315:0.011545:0.012411:0.012257:0.012950:0.005463:0.012257:0.003656:0.011545:0.012411:0.017857:0.012950:0.005330
The  most  important  intervention  in  re-:@0.102424:0.870072:0.475155:0.870072:0.475155:0.854316:0.102424:0.854316:0.008197:0.011738:0.012508:0.005330:0.005482:0.018049:0.012604:0.007466:0.006523:0.005330:0.005494:0.003848:0.018049:0.013123:0.012604:0.005792:0.006523:0.013143:0.011738:0.006523:0.005330:0.005482:0.003848:0.011738:0.006523:0.012508:0.005792:0.010660:0.012508:0.011728:0.006523:0.003848:0.012604:0.011738:0.005330:0.005486:0.003848:0.011738:0.005330:0.005494:0.005713:0.012508:0.006388
ducing mortality is smoking-cessation :@0.084240:0.886569:0.480470:0.886569:0.480470:0.870813:0.084240:0.870813:0.013181:0.011699:0.012450:0.003848:0.011738:0.012950:0.020878:0.018049:0.012604:0.005792:0.006523:0.013133:0.003848:0.003848:0.006523:0.010314:0.020878:0.003848:0.007466:0.020878:0.007466:0.018049:0.012604:0.009660:0.003848:0.011738:0.012950:0.006388:0.012450:0.012508:0.007466:0.007466:0.013143:0.006523:0.003848:0.012604:0.011738:0.005330
programmes.  Screening  for lung  can-:@0.084240:0.903066:0.475155:0.903066:0.475155:0.887310:0.084240:0.887310:0.013123:0.005715:0.012604:0.012950:0.005792:0.013143:0.018049:0.018049:0.012508:0.007466:0.005330:0.005330:0.010855:0.009583:0.012450:0.005713:0.012508:0.012508:0.011738:0.003848:0.011738:0.012950:0.005330:0.010858:0.006042:0.012604:0.005782:0.016202:0.003848:0.011699:0.011738:0.012950:0.005330:0.010862:0.012450:0.013143:0.011738:0.006388
cer in high-risk patients has been shown :@0.084240:0.919576:0.480460:0.919576:0.480460:0.903820:0.084240:0.903820:0.012450:0.012508:0.005792:0.009082:0.003848:0.011738:0.009082:0.011738:0.003848:0.012950:0.011738:0.006388:0.005792:0.003848:0.007466:0.009660:0.009082:0.013123:0.013143:0.006523:0.003848:0.012508:0.011738:0.006523:0.007466:0.009082:0.011738:0.013143:0.007466:0.009082:0.013123:0.012508:0.012508:0.011738:0.009082:0.007466:0.011738:0.012604:0.015990:0.011738:0.005330
to reduce mortality. High-risk factors are :@0.084240:0.936073:0.480478:0.936073:0.480478:0.920317:0.084240:0.920317:0.006523:0.012604:0.009506:0.005713:0.012508:0.013181:0.011699:0.012450:0.012508:0.009506:0.018049:0.012604:0.005792:0.006523:0.013143:0.003848:0.003848:0.006523:0.010314:0.005330:0.009506:0.013143:0.003848:0.012950:0.011738:0.006388:0.005792:0.003848:0.007466:0.009660:0.009506:0.006042:0.013143:0.012450:0.006523:0.012604:0.005792:0.007466:0.009506:0.013143:0.005715:0.012508:0.005330
patients between the ages of 55-74 years, :@0.523640:0.143910:0.919893:0.143910:0.919893:0.128154:0.523640:0.128154:0.013123:0.013143:0.006523:0.003848:0.012508:0.011738:0.006523:0.007466:0.005349:0.013123:0.012508:0.006523:0.015990:0.012508:0.012508:0.011738:0.005340:0.006523:0.011738:0.012508:0.005340:0.013143:0.012950:0.012508:0.007466:0.005349:0.012604:0.006042:0.005349:0.010660:0.010660:0.006388:0.010660:0.010660:0.005363:0.010314:0.012508:0.013143:0.005792:0.007466:0.005330:0.005330
±:@0.523640:0.162087:0.534801:0.162087:0.534801:0.144241:0.523640:0.144241:0.011161
30 pack-year history and smoking ces-:@0.534801:0.160235:0.914531:0.160235:0.914531:0.144479:0.534801:0.144479:0.010660:0.010660:0.010083:0.013123:0.013143:0.012450:0.009660:0.006388:0.010314:0.012508:0.013143:0.005792:0.010083:0.011738:0.003848:0.007466:0.006523:0.012604:0.005792:0.010314:0.010083:0.013143:0.011738:0.013181:0.010083:0.007466:0.018049:0.012604:0.009660:0.003848:0.011738:0.012950:0.010083:0.012450:0.012508:0.007466:0.006388
sation less than 15 years ago. Patients :@0.523640:0.176560:0.919861:0.176560:0.919861:0.160804:0.523640:0.160804:0.007466:0.013143:0.006523:0.003848:0.012604:0.011738:0.012238:0.003848:0.012508:0.007466:0.007466:0.012238:0.006523:0.011738:0.013143:0.011738:0.012238:0.010660:0.010660:0.012238:0.010314:0.012508:0.013143:0.005792:0.007466:0.012238:0.013143:0.012950:0.012604:0.005330:0.012238:0.011392:0.013143:0.006523:0.003848:0.012508:0.011738:0.006523:0.007466:0.005330
are screened with low-dose computed :@0.523640:0.192884:0.919880:0.192884:0.919880:0.177129:0.523640:0.177129:0.013143:0.005715:0.012508:0.012161:0.007466:0.012450:0.005715:0.012508:0.012508:0.011738:0.012508:0.013181:0.012161:0.015990:0.003848:0.006523:0.011738:0.012161:0.003848:0.012604:0.015990:0.006388:0.013181:0.012604:0.007466:0.012508:0.012161:0.012450:0.012604:0.018049:0.013123:0.011699:0.006523:0.012508:0.013181:0.005330
tomography (CT) scans for two years. An-:@0.523640:0.209209:0.914552:0.209209:0.914552:0.193453:0.523640:0.193453:0.006523:0.012604:0.018049:0.012604:0.012950:0.005792:0.013143:0.013123:0.011738:0.010314:0.006206:0.007100:0.015644:0.008197:0.007100:0.006215:0.007466:0.012450:0.013143:0.011738:0.007466:0.006227:0.006042:0.012604:0.005792:0.006215:0.006523:0.015990:0.012604:0.006215:0.010314:0.012508:0.013143:0.005792:0.007466:0.005330:0.006215:0.014239:0.011738:0.006388
nual CT-scans may be considered until the :@0.523640:0.225534:0.919897:0.225534:0.919897:0.209778:0.523640:0.209778:0.011738:0.011699:0.013143:0.003848:0.004541:0.015644:0.008197:0.006388:0.007466:0.012450:0.013143:0.011738:0.007466:0.004541:0.018049:0.013143:0.010314:0.004541:0.013123:0.012508:0.004541:0.012450:0.012604:0.011738:0.007466:0.003848:0.013181:0.012508:0.005713:0.012508:0.013181:0.004541:0.011699:0.011738:0.006523:0.003848:0.003848:0.004541:0.006523:0.011738:0.012508:0.005330
level of risk reduces. There is no benefi t to :@0.523640:0.241859:0.919888:0.241859:0.919888:0.226103:0.523640:0.226103:0.003848:0.012508:0.010660:0.012508:0.003848:0.006267:0.012604:0.006042:0.006256:0.005792:0.003848:0.007466:0.009660:0.006261:0.005713:0.012508:0.013181:0.011699:0.012450:0.012508:0.007466:0.005330:0.006256:0.008197:0.011738:0.012508:0.005703:0.012508:0.006258:0.003848:0.007466:0.006267:0.011738:0.012604:0.006256:0.013123:0.012508:0.011738:0.012508:0.004686:0.000000:0.004684:0.006523:0.006258:0.006523:0.012604:0.005330
screening with chest x-rays.:@0.523640:0.258184:0.777005:0.258184:0.777005:0.242428:0.523640:0.242428:0.007466:0.012450:0.005715:0.012508:0.012508:0.011738:0.003848:0.011738:0.012950:0.005330:0.015990:0.003848:0.006523:0.011738:0.005330:0.012450:0.011738:0.012508:0.007466:0.006523:0.005330:0.009236:0.006388:0.005792:0.013143:0.010314:0.007466:0.005330
2:@0.776982:0.252701:0.783196:0.252701:0.783196:0.243515:0.776982:0.243515:0.006215
PATHOLOGY AND MOLECULAR :@0.523636:0.291606:0.873591:0.291606:0.873591:0.272009:0.523636:0.272009:0.013170:0.017404:0.009878:0.015993:0.019756:0.010348:0.019756:0.019756:0.014581:0.006585:0.017404:0.017404:0.016463:0.006585:0.021167:0.019756:0.010348:0.012230:0.018344:0.015052:0.010348:0.017404:0.013641:0.006585
BIOLOGY:@0.523636:0.310863:0.628058:0.310863:0.628058:0.291266:0.523636:0.291266:0.013641:0.006585:0.019756:0.010348:0.019756:0.019756:0.014581
Lung cancer is divided  into two broad :@0.523636:0.329478:0.919891:0.329478:0.919891:0.313722:0.523636:0.313722:0.008890:0.011699:0.011738:0.012950:0.011372:0.012450:0.013143:0.011738:0.012450:0.012508:0.005792:0.011372:0.003848:0.007466:0.011372:0.013181:0.003848:0.010660:0.003848:0.013181:0.012508:0.013181:0.005330:0.006058:0.003848:0.011738:0.006523:0.012604:0.011372:0.006523:0.015990:0.012604:0.011372:0.013123:0.005715:0.012604:0.013143:0.013181:0.005330
histological groups,  namely non-small-:@0.523636:0.345803:0.914547:0.345803:0.914547:0.330047:0.523636:0.330047:0.011738:0.003848:0.007466:0.006523:0.012604:0.003848:0.012604:0.012950:0.003848:0.012450:0.013143:0.003848:0.017453:0.012950:0.005709:0.012604:0.011699:0.013123:0.007466:0.005330:0.005330:0.012111:0.011738:0.013143:0.018049:0.012508:0.003848:0.010314:0.017453:0.011738:0.012604:0.011738:0.006388:0.007466:0.018049:0.013143:0.003848:0.003848:0.006388
cell and small-cell  lung cancer (SCLC). :@0.523636:0.362128:0.919860:0.362128:0.919860:0.346372:0.523636:0.346372:0.012450:0.012508:0.003848:0.003848:0.011430:0.013143:0.011738:0.013181:0.011430:0.007466:0.018049:0.013143:0.003848:0.003848:0.006388:0.012450:0.012508:0.003848:0.003848:0.005330:0.006123:0.003848:0.011699:0.011738:0.012950:0.011430:0.012450:0.013143:0.011738:0.012450:0.012508:0.005792:0.011430:0.007100:0.009583:0.015644:0.008890:0.015644:0.007100:0.005330:0.005330
The histological diagnosis is non-small-cell :@0.523636:0.378452:0.919862:0.378452:0.919862:0.362696:0.523636:0.362696:0.008197:0.011738:0.012508:0.007029:0.011738:0.003848:0.007466:0.006523:0.012604:0.003848:0.012604:0.012950:0.003848:0.012450:0.013143:0.003848:0.007043:0.013181:0.003848:0.013143:0.012950:0.011738:0.012604:0.007466:0.003848:0.007466:0.007043:0.003848:0.007466:0.007043:0.011738:0.012604:0.011738:0.006388:0.007466:0.018049:0.013143:0.003848:0.003848:0.006388:0.012450:0.012508:0.003848:0.003848:0.005330
lung cancer (NSCLC) in 85% of cases, and :@0.523636:0.394777:0.919897:0.394777:0.919897:0.379021:0.523636:0.379021:0.003848:0.011699:0.011738:0.012950:0.005355:0.012450:0.013143:0.011738:0.012450:0.012508:0.005792:0.005347:0.007100:0.014239:0.009583:0.015644:0.008890:0.015644:0.007100:0.005369:0.003848:0.011738:0.005359:0.010660:0.010660:0.014913:0.005369:0.012604:0.006042:0.005357:0.012450:0.013143:0.007466:0.012508:0.007466:0.005330:0.005369:0.013143:0.011738:0.013181:0.005330
these  are  classifi ed  further  as  adenocar-:@0.523636:0.411102:0.914547:0.411102:0.914547:0.395346:0.523636:0.395346:0.006523:0.011738:0.012508:0.007466:0.012508:0.005330:0.003442:0.013143:0.005713:0.012508:0.005330:0.003444:0.012450:0.003848:0.013143:0.007466:0.007480:0.003848:0.004686:0.000000:0.004684:0.012508:0.013181:0.005330:0.003446:0.006042:0.011699:0.005792:0.006523:0.011738:0.012508:0.005792:0.005330:0.003429:0.013143:0.007466:0.005330:0.003450:0.013143:0.013181:0.012508:0.011738:0.012604:0.012450:0.013143:0.005792:0.006388
cinoma, squamous-cell carcinoma, and :@0.523636:0.427427:0.919858:0.427427:0.919858:0.411671:0.523636:0.411671:0.012450:0.003848:0.011738:0.012604:0.018049:0.013143:0.005330:0.010987:0.007466:0.013123:0.011699:0.013143:0.018049:0.012604:0.011699:0.007466:0.006388:0.012450:0.012508:0.003848:0.003848:0.010987:0.012450:0.013143:0.005659:0.012450:0.003848:0.011738:0.012604:0.018049:0.013143:0.005330:0.010987:0.013143:0.011738:0.013181:0.005330
large-cell carcinoma. SCLC occurs in 15% :@0.523636:0.443751:0.919899:0.443751:0.919899:0.427996:0.523636:0.427996:0.003848:0.013143:0.005813:0.012950:0.012508:0.006388:0.012450:0.012508:0.003848:0.003848:0.006235:0.012450:0.013143:0.005659:0.012450:0.003848:0.011738:0.012604:0.018049:0.013143:0.005330:0.006235:0.009583:0.015644:0.008890:0.015644:0.006235:0.012604:0.012450:0.012450:0.011699:0.005792:0.007466:0.006235:0.003848:0.011738:0.006235:0.010660:0.010660:0.014913:0.005330
of cases. These types of cancer have dif-:@0.523636:0.460076:0.914547:0.460076:0.914547:0.444320:0.523636:0.444320:0.012604:0.006042:0.006756:0.012450:0.013143:0.007466:0.012508:0.007466:0.005330:0.006773:0.008197:0.011738:0.012508:0.007466:0.012508:0.006754:0.006523:0.010314:0.013123:0.012508:0.007466:0.006764:0.012604:0.006042:0.006756:0.012450:0.013143:0.011738:0.012450:0.012508:0.005792:0.006754:0.011738:0.013143:0.010660:0.012508:0.006762:0.013181:0.003848:0.006042:0.006388
ferent pathophysiologies and responses to :@0.523636:0.476401:0.919897:0.476401:0.919897:0.460645:0.523636:0.460645:0.006042:0.012508:0.005709:0.012508:0.011738:0.006523:0.004659:0.013123:0.013143:0.006523:0.011738:0.012604:0.013123:0.011738:0.010314:0.007466:0.003848:0.012604:0.003848:0.012604:0.012950:0.003848:0.012508:0.007466:0.004676:0.013143:0.011738:0.013181:0.004666:0.005711:0.012508:0.007466:0.013123:0.012604:0.011738:0.007466:0.012508:0.007466:0.004676:0.006523:0.012604:0.005330
treatment and are discussed separately.:@0.523636:0.492726:0.885947:0.492726:0.885947:0.476970:0.523636:0.476970:0.006138:0.005328:0.012123:0.012758:0.006138:0.017665:0.012123:0.011353:0.006138:0.004945:0.012758:0.011353:0.012796:0.004945:0.012758:0.005328:0.012123:0.004945:0.012796:0.003464:0.007081:0.012065:0.011315:0.007081:0.007081:0.012123:0.012796:0.004945:0.007081:0.012123:0.012738:0.012758:0.005407:0.012758:0.006138:0.012123:0.003464:0.009929:0.005330
3:@0.885554:0.487055:0.891769:0.487055:0.891769:0.477870:0.885554:0.477870:0.006215
There  are  many  genetic  mutations  in :@0.541818:0.508994:0.919892:0.508994:0.919892:0.493238:0.541818:0.493238:0.008005:0.011545:0.012315:0.005521:0.012315:0.005330:0.007341:0.012950:0.005519:0.012315:0.005330:0.007341:0.017857:0.012950:0.011545:0.010122:0.005330:0.007341:0.012758:0.012315:0.011545:0.012315:0.006331:0.003656:0.012257:0.005330:0.007341:0.017857:0.011507:0.006331:0.012950:0.006331:0.003656:0.012411:0.011545:0.007274:0.005330:0.007339:0.003656:0.011736:0.005330
patients with lung cancer. The epidermal :@0.523634:0.525319:0.919898:0.525319:0.919898:0.509563:0.523634:0.509563:0.012931:0.012950:0.006331:0.003656:0.012315:0.011545:0.006331:0.007274:0.008659:0.015798:0.003656:0.006331:0.011545:0.008659:0.003656:0.011507:0.011545:0.012758:0.008659:0.012257:0.012950:0.011545:0.012257:0.012315:0.004187:0.005138:0.008659:0.008005:0.011545:0.012315:0.008659:0.012315:0.012931:0.003656:0.012989:0.012315:0.006131:0.017857:0.012950:0.003850:0.005330
growth  factor  receptor  (EGFR)  and  the :@0.523634:0.541643:0.919906:0.541643:0.919906:0.525887:0.523634:0.525887:0.012758:0.005521:0.012411:0.015798:0.006331:0.011545:0.005330:0.007166:0.005850:0.012950:0.012257:0.006331:0.012411:0.005600:0.005330:0.007166:0.005521:0.012315:0.012257:0.012315:0.012931:0.006331:0.012411:0.005600:0.005330:0.007166:0.006908:0.010122:0.016587:0.009140:0.011488:0.006908:0.005330:0.007166:0.012950:0.011545:0.012989:0.005330:0.007166:0.006331:0.011545:0.012506:0.005330
anaplastic lymphoma kinase (ALK) gene :@0.523634:0.557968:0.919890:0.557968:0.919890:0.542212:0.523634:0.542212:0.012950:0.011545:0.012950:0.012931:0.003656:0.012950:0.007274:0.006331:0.003656:0.012257:0.010256:0.003656:0.010122:0.017857:0.012931:0.011545:0.012411:0.017857:0.012950:0.010256:0.009467:0.003656:0.011545:0.012950:0.007274:0.012315:0.010256:0.006908:0.014047:0.008698:0.011180:0.006908:0.010256:0.012758:0.012315:0.011545:0.012506:0.005330
mutations predict response to therapy (dis-:@0.523634:0.574293:0.914520:0.574293:0.914520:0.558537:0.523634:0.558537:0.017857:0.011507:0.006331:0.012950:0.006331:0.003656:0.012411:0.011545:0.007274:0.005138:0.012931:0.005521:0.012315:0.012989:0.003656:0.012257:0.006331:0.005138:0.005521:0.012315:0.007274:0.012931:0.012411:0.011545:0.007274:0.012315:0.005138:0.006331:0.012411:0.005138:0.006331:0.011545:0.012315:0.005600:0.012950:0.012931:0.010122:0.005138:0.006908:0.012989:0.003656:0.007274:0.006388
cussed later). The EGFR and the ALK are :@0.523634:0.590618:0.919889:0.590618:0.919889:0.574862:0.523634:0.574862:0.012257:0.011507:0.007274:0.007274:0.012315:0.012989:0.008948:0.003656:0.012950:0.006331:0.012315:0.005600:0.006908:0.005138:0.008948:0.008005:0.011545:0.012315:0.008948:0.010122:0.016587:0.009140:0.011488:0.008948:0.012950:0.011545:0.012989:0.008948:0.006331:0.011545:0.012315:0.008948:0.014047:0.008698:0.011180:0.008948:0.012950:0.005521:0.012506:0.005330
transmembrane receptors. When a ligand :@0.523634:0.606943:0.919910:0.606943:0.919910:0.591187:0.523634:0.591187:0.006331:0.005600:0.012950:0.011545:0.007274:0.017857:0.012315:0.017857:0.012931:0.005600:0.012950:0.011545:0.012315:0.006850:0.005521:0.012315:0.012257:0.012315:0.012931:0.006331:0.012411:0.005600:0.007274:0.005138:0.006850:0.018280:0.011545:0.012315:0.011545:0.006850:0.012950:0.006850:0.003656:0.003656:0.012758:0.012950:0.011545:0.013181:0.005330
binds, signal transduction cascade results, :@0.523634:0.623267:0.919869:0.623267:0.919869:0.607511:0.523634:0.607511:0.012931:0.003656:0.011545:0.012989:0.007274:0.005138:0.007235:0.007274:0.003656:0.012758:0.011545:0.012950:0.003656:0.007235:0.006331:0.005600:0.012950:0.011545:0.007274:0.012989:0.011507:0.012257:0.006331:0.003656:0.012411:0.011545:0.007235:0.012257:0.012950:0.007274:0.012257:0.012950:0.012989:0.012315:0.007235:0.005521:0.012315:0.007274:0.011507:0.003656:0.006331:0.007274:0.005328:0.005330
which causes cellular proliferation and oth-:@0.523634:0.639592:0.914560:0.639592:0.914560:0.623836:0.523634:0.623836:0.015798:0.011545:0.003656:0.012257:0.011545:0.004791:0.012257:0.012950:0.011507:0.007274:0.012315:0.007274:0.004791:0.012257:0.012315:0.003656:0.003656:0.011507:0.003656:0.012950:0.005600:0.004791:0.012931:0.005521:0.012411:0.003656:0.003656:0.005850:0.012315:0.005600:0.012950:0.006331:0.003656:0.012411:0.011545:0.004791:0.012950:0.011545:0.012989:0.004791:0.012411:0.006331:0.011545:0.006388
er hallmarks of malignancy. Tyrosine kinase :@0.523634:0.655917:0.919902:0.655917:0.919902:0.640161:0.523634:0.640161:0.012315:0.005600:0.005407:0.011545:0.012950:0.003656:0.003656:0.017857:0.012950:0.005600:0.009467:0.007274:0.005407:0.012411:0.005850:0.005407:0.017857:0.012950:0.003656:0.003656:0.012758:0.011545:0.012950:0.011545:0.012257:0.010122:0.005138:0.005407:0.008095:0.010122:0.005521:0.012411:0.007274:0.003656:0.011545:0.012315:0.005407:0.009467:0.003656:0.011545:0.012950:0.007274:0.012506:0.005330
inhibitors (TKIs) inhibit this pathway.:@0.523634:0.672242:0.837304:0.672242:0.837304:0.656486:0.523634:0.656486:0.003656:0.011545:0.011545:0.003656:0.012931:0.003656:0.006331:0.012411:0.005600:0.007274:0.005138:0.006908:0.008005:0.011180:0.004156:0.007274:0.006908:0.005138:0.003656:0.011545:0.011545:0.003656:0.012931:0.003656:0.006331:0.005138:0.006331:0.011545:0.003656:0.007274:0.005138:0.012931:0.012950:0.006331:0.011545:0.015798:0.012950:0.010122:0.005330
3:@0.837117:0.666571:0.843332:0.666571:0.843332:0.657385:0.837117:0.657385:0.006215
Tumour cells also express the pro-:@0.541818:0.688510:0.914556:0.688510:0.914556:0.672754:0.541818:0.672754:0.007503:0.011892:0.018242:0.012796:0.011892:0.005984:0.017280:0.012642:0.012700:0.004041:0.004041:0.007658:0.017280:0.013335:0.004041:0.007658:0.012796:0.017280:0.012700:0.009429:0.013316:0.005905:0.012700:0.007658:0.007658:0.017280:0.006716:0.011930:0.012700:0.017280:0.013316:0.005905:0.012796:0.006388
grammed  death  ligand  (PDL1).  PDL1 :@0.523634:0.704835:0.919877:0.704835:0.919877:0.689079:0.523634:0.689079:0.013143:0.005984:0.013335:0.018242:0.018242:0.012700:0.013373:0.005330:0.011170:0.013373:0.012700:0.013335:0.006716:0.011930:0.005330:0.011170:0.004041:0.004041:0.013143:0.013335:0.011930:0.013373:0.005330:0.011170:0.007293:0.011584:0.014509:0.009082:0.010853:0.007293:0.005523:0.005330:0.011170:0.011584:0.014509:0.009082:0.010664:0.005330
binds to the programmed death protein :@0.523634:0.721159:0.919865:0.721159:0.919865:0.705403:0.523634:0.705403:0.013316:0.004041:0.011930:0.013373:0.007658:0.007485:0.006716:0.012796:0.007485:0.006716:0.011930:0.012700:0.007485:0.013316:0.005905:0.012796:0.013143:0.005984:0.013335:0.018242:0.018242:0.012700:0.013373:0.007485:0.013373:0.012700:0.013335:0.006716:0.011930:0.007485:0.013316:0.005905:0.012796:0.006716:0.012700:0.004041:0.011734:0.005330
(PD1) on the patient’s T-cells. This bond in-:@0.523634:0.737484:0.914562:0.737484:0.914562:0.721728:0.523634:0.721728:0.007293:0.011584:0.014509:0.010853:0.007293:0.004657:0.012796:0.011930:0.004657:0.006716:0.011930:0.012700:0.004657:0.013316:0.013335:0.006716:0.004041:0.012700:0.011930:0.006716:0.006947:0.007658:0.004657:0.008390:0.006581:0.012642:0.012700:0.004041:0.004041:0.007658:0.005523:0.004657:0.008390:0.011930:0.004041:0.007658:0.004657:0.013316:0.012796:0.011930:0.013373:0.004657:0.004041:0.011930:0.006388
hibits the immune function of the patient, :@0.523634:0.753809:0.919910:0.753809:0.919910:0.738053:0.523634:0.738053:0.011930:0.004041:0.013316:0.004041:0.006716:0.007658:0.005369:0.006716:0.011930:0.012700:0.005369:0.004041:0.018242:0.018242:0.011892:0.011930:0.012700:0.005369:0.006235:0.011892:0.011930:0.012642:0.006716:0.004041:0.012796:0.011930:0.005369:0.012796:0.006235:0.005369:0.006716:0.011930:0.012700:0.005369:0.013316:0.013335:0.006716:0.004041:0.012700:0.011930:0.006716:0.005328:0.005330
promoting tumour growth. Immune ther-:@0.523634:0.770134:0.914595:0.770134:0.914595:0.754378:0.523634:0.754378:0.013316:0.005905:0.012796:0.018242:0.012796:0.006716:0.004041:0.011930:0.013143:0.007774:0.006716:0.011892:0.018242:0.012796:0.011892:0.005984:0.007774:0.013143:0.005904:0.012796:0.016183:0.006716:0.011930:0.005523:0.007774:0.004541:0.018242:0.018242:0.011892:0.011930:0.012700:0.007774:0.006716:0.011930:0.012700:0.005984:0.006388
apy  includes  antibodies  against  either :@0.523634:0.786458:0.919856:0.786458:0.919856:0.770703:0.523634:0.770703:0.013335:0.013316:0.010506:0.005330:0.007549:0.004041:0.011930:0.012642:0.004041:0.011892:0.013373:0.012700:0.007658:0.005330:0.007549:0.013335:0.011930:0.006716:0.004041:0.013316:0.012796:0.013373:0.004041:0.012700:0.007658:0.005330:0.007551:0.013335:0.013143:0.013335:0.004041:0.011930:0.007658:0.006716:0.005330:0.007549:0.012700:0.004041:0.006716:0.011930:0.012700:0.005788:0.005330
PD1 or PDL1.:@0.523634:0.802783:0.641763:0.802783:0.641763:0.787027:0.523634:0.787027:0.011584:0.014509:0.010853:0.005523:0.012796:0.005984:0.005523:0.011584:0.014509:0.009082:0.010853:0.005330
4:@0.641944:0.797128:0.648159:0.797128:0.648159:0.787942:0.641944:0.787942:0.006215
DIAGNOSIS AND PRE-TREATMENT :@0.523636:0.835710:0.861875:0.835710:0.861875:0.817894:0.523636:0.817894:0.014966:0.005987:0.015822:0.017960:0.015822:0.017960:0.011118:0.005987:0.011118:0.005987:0.015822:0.015822:0.014966:0.005987:0.011973:0.012401:0.011118:0.008980:0.008980:0.012401:0.011118:0.015822:0.008980:0.019242:0.011118:0.015822:0.008980:0.005987
EVALUATION:@0.523636:0.853496:0.653201:0.853496:0.653201:0.835680:0.523636:0.835680:0.011118:0.014966:0.015822:0.009407:0.013683:0.015822:0.008980:0.005987:0.017960:0.015822
Patients with lung cancer usually have a :@0.523636:0.870965:0.919887:0.870965:0.919887:0.855209:0.523636:0.855209:0.011392:0.013143:0.006523:0.003848:0.012508:0.011738:0.006523:0.007466:0.008024:0.015990:0.003848:0.006523:0.011738:0.008024:0.003848:0.011699:0.011738:0.012950:0.008024:0.012450:0.013143:0.011738:0.012450:0.012508:0.005792:0.008024:0.011699:0.007466:0.011699:0.013143:0.003848:0.003848:0.010314:0.008036:0.011738:0.013143:0.010660:0.012508:0.008024:0.013143:0.005330
mass on chest radiograph. A tissue diag-:@0.523636:0.887290:0.914540:0.887290:0.914540:0.871534:0.523636:0.871534:0.018049:0.013143:0.007466:0.007466:0.007653:0.012604:0.011738:0.007639:0.012450:0.011738:0.012508:0.007466:0.006523:0.007639:0.005792:0.013143:0.013181:0.003848:0.012604:0.012950:0.005792:0.013143:0.013123:0.011738:0.005330:0.007639:0.014239:0.007639:0.006523:0.003848:0.007466:0.007466:0.011699:0.012508:0.007639:0.013181:0.003848:0.013143:0.012950:0.006388
nosis is mandatory.  Fine-needle aspira-:@0.523636:0.903615:0.914526:0.903615:0.914526:0.887859:0.523636:0.887859:0.011738:0.012604:0.007466:0.003848:0.007466:0.013412:0.003848:0.007466:0.013412:0.018049:0.013143:0.011738:0.013181:0.013143:0.006523:0.012604:0.005792:0.010314:0.005330:0.005330:0.008072:0.009333:0.003848:0.011738:0.012508:0.006388:0.011738:0.012508:0.012498:0.013181:0.003848:0.012508:0.013412:0.013143:0.007466:0.013123:0.003848:0.005792:0.013143:0.006388
tion  and  biopsy can  be  accomplished :@0.523636:0.919940:0.919868:0.919940:0.919868:0.904184:0.523636:0.904184:0.006523:0.003848:0.012604:0.011738:0.005330:0.006719:0.013143:0.011738:0.013181:0.005330:0.006725:0.013123:0.003848:0.012604:0.013123:0.007466:0.010314:0.012065:0.012450:0.013143:0.011738:0.005330:0.006723:0.013123:0.012508:0.005330:0.006725:0.013143:0.012450:0.012450:0.012604:0.018049:0.013123:0.003848:0.003848:0.007466:0.011738:0.012508:0.013181:0.005330
under CT-guidance or at bronchoscopy, :@0.523636:0.936265:0.919895:0.936265:0.919895:0.920509:0.523636:0.920509:0.011699:0.011738:0.013181:0.012508:0.005792:0.008736:0.015644:0.008197:0.006388:0.012950:0.011699:0.003848:0.013181:0.013143:0.011738:0.012450:0.012508:0.008736:0.012604:0.005792:0.008736:0.013143:0.006523:0.008736:0.013123:0.005715:0.012604:0.011738:0.012450:0.011738:0.012604:0.007466:0.012450:0.012604:0.013123:0.010314:0.005330:0.005330
Lung Cancer:@0.084848:0.111850:0.350821:0.111850:0.350821:0.076219:0.084848:0.076219:0.018815:0.025657:0.025657:0.028222:0.011973:0.033354:0.028222:0.025657:0.027367:0.027367:0.013683
For full prescribing information refer to the package insert approved by the Medicines Regulatory Authority.:@1.073949:0.662597:1.699419:0.662597:1.699419:0.651379:1.073949:0.651379:0.006170:0.007774:0.004054:0.005093:0.004015:0.006735:0.002437:0.002437:0.005285:0.007697:0.004052:0.007068:0.005311:0.006632:0.004631:0.002437:0.007697:0.002437:0.006825:0.007697:0.005285:0.002437:0.006825:0.003629:0.007774:0.004631:0.010288:0.007684:0.003951:0.002437:0.007774:0.006825:0.005285:0.004052:0.006940:0.003630:0.007068:0.004054:0.005157:0.003566:0.007646:0.005157:0.003951:0.006722:0.007068:0.005285:0.007697:0.007684:0.006632:0.005592:0.007684:0.007697:0.007068:0.005285:0.002437:0.006825:0.005311:0.007068:0.004631:0.003757:0.005157:0.007684:0.007697:0.007697:0.004054:0.007389:0.006183:0.007068:0.007697:0.005285:0.007312:0.006286:0.005156:0.003951:0.006722:0.007068:0.005285:0.011019:0.007068:0.007697:0.002437:0.006632:0.002437:0.006825:0.007068:0.005181:0.005285:0.007453:0.007068:0.007697:0.006735:0.002437:0.007684:0.003566:0.007774:0.004631:0.006286:0.004514:0.008916:0.006735:0.003951:0.006722:0.007774:0.004631:0.002437:0.003951:0.005773:0.002412
S4 CIPLA DOCETAXEL 20 (Solution for infusion). Each single-dose vial contains docetaxel trihydrate equivalent to 20 mg docetaxel (anhydrous) :@1.073949:0.683808:1.909029:0.683808:1.909029:0.672590:1.073949:0.672590:0.006927:0.007325:0.004900:0.009121:0.003464:0.007351:0.006106:0.008465:0.005285:0.009313:0.010519:0.009121:0.007043:0.005555:0.008852:0.008377:0.007043:0.005721:0.005157:0.006440:0.007107:0.005285:0.003579:0.007056:0.007774:0.002437:0.006735:0.003951:0.002437:0.007774:0.006825:0.005092:0.003630:0.007774:0.004054:0.005285:0.002437:0.006825:0.004015:0.006735:0.005311:0.002437:0.007774:0.006439:0.003388:0.002412:0.005285:0.006785:0.007684:0.006632:0.006722:0.005285:0.005311:0.002437:0.006825:0.007697:0.002437:0.007068:0.004926:0.007697:0.007774:0.005311:0.007068:0.004898:0.006568:0.002437:0.007684:0.002437:0.005157:0.006632:0.007774:0.006825:0.003565:0.007684:0.002437:0.006825:0.005183:0.005157:0.007697:0.007774:0.006632:0.007068:0.003566:0.007684:0.006196:0.007068:0.002437:0.005156:0.003951:0.004631:0.002437:0.006337:0.006414:0.007697:0.004054:0.007684:0.003566:0.007068:0.005285:0.007068:0.007697:0.006735:0.002437:0.006309:0.007684:0.002437:0.007068:0.006825:0.003757:0.005157:0.003568:0.007646:0.005157:0.006440:0.007107:0.005285:0.010288:0.007697:0.005156:0.007697:0.007774:0.006632:0.007068:0.003566:0.007684:0.006196:0.007068:0.002437:0.005285:0.003258:0.007684:0.006825:0.006336:0.006414:0.007697:0.004054:0.007774:0.006735:0.005054:0.003772:0.005285
in 0,5 ml polysorbate 80. Inactive ingredients include anhydrous citric acid and polysorbate 80. Reg. No.: 41/26/0162. :@1.073949:0.694409:1.755990:0.694409:1.755990:0.683191:1.073949:0.683191:0.002437:0.006825:0.005285:0.007107:0.002463:0.006990:0.005285:0.010288:0.002437:0.005285:0.007697:0.007774:0.002437:0.006541:0.005311:0.007774:0.004631:0.007697:0.007684:0.003566:0.007068:0.005285:0.006953:0.006722:0.002412:0.005285:0.003464:0.006825:0.007684:0.006632:0.003951:0.002437:0.006182:0.007068:0.005285:0.002437:0.006825:0.007697:0.004054:0.007068:0.007697:0.002437:0.007068:0.006825:0.003951:0.005181:0.005285:0.002437:0.006825:0.006632:0.002437:0.006735:0.007697:0.007068:0.005157:0.007684:0.006825:0.006336:0.006414:0.007697:0.004054:0.007774:0.006735:0.005183:0.005157:0.006632:0.002437:0.003951:0.004631:0.002437:0.006632:0.005156:0.007684:0.006632:0.002437:0.007697:0.005157:0.007684:0.006825:0.007697:0.005285:0.007697:0.007774:0.002437:0.006540:0.005311:0.007774:0.004631:0.007697:0.007684:0.003568:0.007068:0.005285:0.006953:0.006722:0.002412:0.005285:0.007452:0.007068:0.007697:0.002412:0.005285:0.009634:0.007389:0.002412:0.002412:0.005285:0.007325:0.003861:0.005027:0.006440:0.006966:0.005285:0.007107:0.003861:0.007030:0.006440:0.002412:0.005285
Pharmacological classification: A 26 Cytostatic agents.:@1.073949:0.705010:1.387700:0.705010:1.387700:0.693792:1.073949:0.693792:0.007351:0.006722:0.007684:0.004631:0.010288:0.007684:0.006632:0.007774:0.002437:0.007774:0.007697:0.002437:0.006632:0.007684:0.002437:0.005157:0.006632:0.002437:0.007684:0.005311:0.005311:0.002437:0.004015:0.002437:0.006632:0.007684:0.003951:0.002437:0.007774:0.006825:0.002412:0.004513:0.008467:0.005157:0.006440:0.006902:0.004900:0.008736:0.006607:0.003566:0.007774:0.005311:0.003566:0.007684:0.003951:0.002437:0.006632:0.005157:0.007684:0.007697:0.007068:0.006825:0.003951:0.005311:0.002412
S4 CIPLA DOCETAXEL 80 (Solution for infusion). Each single-dose vial contains docetaxel trihydrate equivalent to 80 mg docetaxel (anhydrous) :@1.073949:0.715611:1.910313:0.715611:1.910313:0.704393:1.073949:0.704393:0.006927:0.007325:0.004900:0.009121:0.003464:0.007351:0.006106:0.008465:0.005285:0.009313:0.010519:0.009121:0.007043:0.005555:0.008852:0.008377:0.007043:0.005721:0.005285:0.006953:0.007107:0.005285:0.003579:0.007056:0.007774:0.002437:0.006735:0.003951:0.002437:0.007774:0.006825:0.005092:0.003629:0.007774:0.004052:0.005285:0.002437:0.006825:0.004015:0.006735:0.005311:0.002437:0.007774:0.006441:0.003385:0.002412:0.005285:0.006786:0.007684:0.006632:0.006722:0.005285:0.005311:0.002437:0.006825:0.007697:0.002437:0.007068:0.004926:0.007697:0.007774:0.005311:0.007068:0.004899:0.006568:0.002437:0.007684:0.002437:0.005156:0.006632:0.007774:0.006825:0.003566:0.007684:0.002437:0.006825:0.005183:0.005157:0.007697:0.007774:0.006632:0.007068:0.003566:0.007684:0.006195:0.007068:0.002437:0.005157:0.003951:0.004631:0.002437:0.006337:0.006414:0.007697:0.004054:0.007684:0.003566:0.007068:0.005285:0.007068:0.007697:0.006735:0.002437:0.006310:0.007684:0.002437:0.007068:0.006825:0.003759:0.005157:0.003566:0.007646:0.005285:0.006953:0.007107:0.005285:0.010288:0.007697:0.005156:0.007697:0.007774:0.006632:0.007068:0.003566:0.007684:0.006196:0.007068:0.002437:0.005285:0.003257:0.007684:0.006825:0.006337:0.006414:0.007697:0.004054:0.007774:0.006735:0.005054:0.003772:0.005285
in 2,0 ml polysorbate 80. Inactive ingredients include anhydrous citric acid and polysorbate 80. Reg. No.: 41/26/0163. :@1.073949:0.726212:1.756003:0.726212:1.756003:0.714993:1.073949:0.714993:0.002437:0.006825:0.005157:0.006440:0.002463:0.007107:0.005285:0.010288:0.002437:0.005285:0.007697:0.007774:0.002437:0.006541:0.005311:0.007774:0.004631:0.007697:0.007684:0.003565:0.007068:0.005285:0.006953:0.006722:0.002412:0.005285:0.003464:0.006825:0.007684:0.006632:0.003951:0.002437:0.006182:0.007068:0.005285:0.002437:0.006825:0.007697:0.004054:0.007068:0.007697:0.002437:0.007068:0.006825:0.003951:0.005181:0.005285:0.002437:0.006825:0.006632:0.002437:0.006735:0.007697:0.007068:0.005157:0.007684:0.006825:0.006336:0.006414:0.007697:0.004054:0.007774:0.006735:0.005183:0.005157:0.006632:0.002437:0.003951:0.004631:0.002437:0.006632:0.005156:0.007684:0.006632:0.002437:0.007697:0.005157:0.007684:0.006825:0.007697:0.005285:0.007697:0.007774:0.002437:0.006542:0.005311:0.007774:0.004631:0.007697:0.007684:0.003565:0.007068:0.005285:0.006953:0.006722:0.002412:0.005285:0.007452:0.007068:0.007697:0.002412:0.005285:0.009634:0.007389:0.002412:0.002412:0.005285:0.007325:0.003861:0.005027:0.006440:0.006966:0.005285:0.007107:0.003861:0.007222:0.006940:0.002412:0.005285
Pharmacological classification: A.26 Cytostatic agents.:@1.073949:0.736813:1.385914:0.736813:1.385914:0.725594:1.073949:0.725594:0.007351:0.006722:0.007684:0.004631:0.010288:0.007684:0.006632:0.007774:0.002437:0.007774:0.007697:0.002437:0.006632:0.007684:0.002437:0.005157:0.006632:0.002437:0.007684:0.005311:0.005311:0.002437:0.004015:0.002437:0.006632:0.007684:0.003951:0.002437:0.007774:0.006825:0.002412:0.004513:0.009236:0.002604:0.006440:0.006902:0.004900:0.008736:0.006607:0.003566:0.007774:0.005311:0.003564:0.007684:0.003951:0.002437:0.006632:0.005157:0.007684:0.007697:0.007068:0.006825:0.003951:0.005311:0.002412
 S1 SOLVENT FOR CIPLA DOCETAXEL 20 / 80 (Solvent). Each vial contains 13,0 % m/v ethanol 95 % v/v. Reg. No.: 44/32.2/0393, 94. :@1.073949:0.747414:1.841737:0.747414:1.841737:0.736195:1.073949:0.736195:0.001244:0.007056:0.003861:0.005093:0.007056:0.010519:0.005080:0.009095:0.007043:0.009634:0.005617:0.005285:0.006299:0.010519:0.007517:0.004900:0.009121:0.003464:0.007351:0.006106:0.008467:0.005285:0.009313:0.010519:0.009121:0.007043:0.005552:0.008853:0.008377:0.007043:0.005721:0.005157:0.006440:0.007107:0.004516:0.004900:0.005285:0.006953:0.007107:0.005285:0.003578:0.007056:0.007774:0.002437:0.006183:0.007068:0.006825:0.003438:0.003387:0.002412:0.005285:0.006786:0.007684:0.006632:0.006722:0.004899:0.006568:0.002437:0.007684:0.002437:0.005157:0.006632:0.007774:0.006825:0.003566:0.007684:0.002437:0.006825:0.005183:0.004965:0.003861:0.007068:0.002463:0.007107:0.005285:0.009403:0.005285:0.010288:0.004899:0.006183:0.005285:0.007068:0.003951:0.006722:0.007684:0.006825:0.007774:0.002437:0.005029:0.006825:0.006991:0.005285:0.009403:0.004900:0.005798:0.004900:0.005670:0.002412:0.005285:0.007452:0.007068:0.007697:0.002412:0.005285:0.009634:0.007389:0.002412:0.002412:0.005285:0.007325:0.007325:0.005157:0.007197:0.006440:0.002603:0.006440:0.005285:0.007107:0.006812:0.006568:0.007068:0.002463:0.005029:0.006568:0.007325:0.002412:0.005285
Pharmacological classification: A.32.2 Other:@1.073949:0.758015:1.325587:0.758015:1.325587:0.746796:1.073949:0.746796:0.007351:0.006722:0.007684:0.004631:0.010288:0.007684:0.006632:0.007774:0.002437:0.007774:0.007697:0.002437:0.006632:0.007684:0.002437:0.005156:0.006632:0.002437:0.007684:0.005311:0.005311:0.002437:0.004015:0.002437:0.006632:0.007684:0.003951:0.002437:0.007774:0.006825:0.002412:0.004516:0.009236:0.002412:0.007197:0.006440:0.002604:0.006440:0.004900:0.010519:0.003951:0.006722:0.007068:0.004631
S4 CIPLA PACLITAXEL 30 mg / 5 ml, 100 mg / 16.7 ml, 300 mg / 50 ml (Concentrate for dilution for infusion). Each vial contains :@1.073949:0.768616:1.817090:0.768616:1.817090:0.757397:1.073949:0.757397:0.006927:0.007325:0.004900:0.009121:0.003464:0.007351:0.006106:0.008465:0.005285:0.006581:0.008723:0.009121:0.006363:0.003464:0.005555:0.008852:0.008377:0.007043:0.005721:0.005093:0.007197:0.007107:0.005285:0.010288:0.007697:0.004516:0.004899:0.004965:0.006991:0.005285:0.010288:0.002437:0.002463:0.004963:0.003861:0.007107:0.007107:0.005285:0.010288:0.007697:0.004514:0.004900:0.004966:0.003861:0.006708:0.002155:0.006390:0.005285:0.010288:0.002437:0.002463:0.005092:0.007197:0.007107:0.007107:0.005285:0.010288:0.007697:0.004514:0.004900:0.004965:0.007120:0.007107:0.005285:0.010288:0.002437:0.005285:0.003385:0.008993:0.007774:0.006825:0.006632:0.007068:0.006825:0.003951:0.004054:0.007684:0.003566:0.007068:0.005093:0.003630:0.007774:0.004052:0.005157:0.007697:0.002437:0.002437:0.006735:0.003951:0.002437:0.007774:0.006825:0.005092:0.003630:0.007774:0.004054:0.005285:0.002437:0.006825:0.004015:0.006735:0.005311:0.002437:0.007774:0.006439:0.003387:0.002412:0.005285:0.006786:0.007684:0.006632:0.006722:0.004900:0.006568:0.002437:0.007684:0.002437:0.005157:0.006632:0.007774:0.006825:0.003565:0.007684:0.002437:0.006825:0.005183:0.005285
30 mg / 100 mg / 300 mg paclitaxel per 5 ml / 16.7 ml / 50 ml. Contains ethanol 49,7 % v/v, polyoxyethylated castor oil and anhydrous citric acid :@1.073949:0.779217:1.926216:0.779217:1.926216:0.767998:1.073949:0.767998:0.007197:0.007107:0.005285:0.010288:0.007697:0.004514:0.004900:0.004965:0.003861:0.007107:0.007107:0.005285:0.010288:0.007697:0.004516:0.004899:0.005093:0.007197:0.007107:0.007107:0.005285:0.010288:0.007697:0.005285:0.007697:0.007684:0.006632:0.002437:0.002437:0.003565:0.007684:0.006195:0.007068:0.002437:0.005285:0.007697:0.007068:0.004054:0.004962:0.006991:0.005285:0.010288:0.002437:0.004516:0.004899:0.004965:0.003861:0.006710:0.002155:0.006388:0.005285:0.010288:0.002437:0.004514:0.004899:0.004966:0.007120:0.007107:0.005285:0.010288:0.002437:0.002412:0.004899:0.008994:0.007774:0.006825:0.003565:0.007684:0.002437:0.006825:0.005183:0.005285:0.007068:0.003951:0.006722:0.007684:0.006825:0.007774:0.002437:0.005285:0.006939:0.006440:0.002463:0.006388:0.005285:0.009403:0.004900:0.005798:0.004900:0.005478:0.002463:0.005285:0.007697:0.007774:0.002437:0.006285:0.007582:0.006581:0.006286:0.007068:0.003951:0.006337:0.006671:0.002437:0.007684:0.003565:0.007068:0.007697:0.005157:0.006632:0.007684:0.005311:0.003566:0.007774:0.004054:0.005157:0.007774:0.002437:0.002437:0.005156:0.007684:0.006825:0.007697:0.005157:0.007684:0.006825:0.006337:0.006414:0.007697:0.004054:0.007774:0.006735:0.005183:0.005156:0.006632:0.002437:0.003951:0.004631:0.002437:0.006632:0.005157:0.007684:0.006632:0.002437:0.007697:0.005285
as excipients. Reg. No.: 41/26/0423, 24, 25. Pharmacological classification: A 26 Cytostatic agents.:@1.073949:0.789818:1.638941:0.789818:1.638941:0.778599:1.073949:0.778599:0.007684:0.005183:0.005285:0.006555:0.006324:0.006632:0.002437:0.007697:0.002437:0.007068:0.006825:0.003951:0.005311:0.002412:0.005285:0.007453:0.007068:0.007697:0.002412:0.005285:0.009634:0.007389:0.002412:0.002412:0.005285:0.007325:0.003861:0.005029:0.006440:0.006966:0.005285:0.007107:0.007325:0.006440:0.007067:0.002463:0.005157:0.006440:0.007325:0.002463:0.005157:0.006440:0.007120:0.002412:0.005285:0.007351:0.006722:0.007684:0.004631:0.010288:0.007684:0.006632:0.007774:0.002437:0.007774:0.007697:0.002437:0.006632:0.007684:0.002437:0.005158:0.006632:0.002437:0.007684:0.005311:0.005311:0.002437:0.004015:0.002437:0.006632:0.007684:0.003951:0.002437:0.007774:0.006825:0.002412:0.004513:0.008468:0.005157:0.006440:0.006900:0.004900:0.008736:0.006607:0.003566:0.007774:0.005311:0.003566:0.007684:0.003951:0.002437:0.006632:0.005157:0.007684:0.007697:0.007068:0.006825:0.003951:0.005311:0.002412
S4  PCH PACLITAXEL 30 / 100 / 300. Each vial contains 30 mg / 100 mg / 300 mg paclitaxel per 5 ml / 16,7 ml / 50 ml (6 mg/ml). :@1.073949:0.800419:1.836193:0.800419:1.836193:0.789200:1.073949:0.789200:0.006927:0.007325:0.005285:0.005285:0.007351:0.009121:0.009326:0.005285:0.006580:0.008723:0.009121:0.006363:0.003464:0.005555:0.008852:0.008377:0.007043:0.005721:0.005093:0.007197:0.007107:0.004514:0.004902:0.004963:0.003861:0.007107:0.007107:0.004516:0.004900:0.005093:0.007197:0.007107:0.006722:0.002412:0.005285:0.006785:0.007684:0.006632:0.006722:0.004900:0.006568:0.002437:0.007684:0.002437:0.005157:0.006632:0.007774:0.006825:0.003566:0.007684:0.002437:0.006825:0.005181:0.005093:0.007197:0.007107:0.005285:0.010288:0.007697:0.004516:0.004900:0.004965:0.003861:0.007107:0.007107:0.005285:0.010288:0.007697:0.004516:0.004899:0.005093:0.007197:0.007107:0.007107:0.005285:0.010288:0.007697:0.005285:0.007697:0.007684:0.006632:0.002437:0.002437:0.003565:0.007684:0.006196:0.007068:0.002437:0.005285:0.007697:0.007068:0.004054:0.004963:0.006991:0.005285:0.010288:0.002437:0.004516:0.004900:0.004965:0.003861:0.007094:0.002463:0.006388:0.005285:0.010288:0.002437:0.004514:0.004900:0.004965:0.007120:0.007107:0.005285:0.010288:0.002437:0.005285:0.003772:0.006900:0.005285:0.010288:0.007697:0.004900:0.010288:0.002437:0.003387:0.002412:0.005285
Reg. No.: A40/26/0609, 10, 11. Pharmacological classification: A 26 Cytostatic agents.:@1.073949:0.811020:1.560353:0.811020:1.560353:0.799801:1.073949:0.799801:0.007453:0.007068:0.007697:0.002412:0.005285:0.009634:0.007389:0.002412:0.002412:0.004516:0.009236:0.007325:0.006979:0.005029:0.006440:0.006966:0.005285:0.007107:0.007222:0.007107:0.006439:0.002463:0.004965:0.003861:0.007107:0.002463:0.004963:0.003861:0.003861:0.002412:0.005285:0.007351:0.006722:0.007684:0.004631:0.010288:0.007684:0.006632:0.007774:0.002437:0.007774:0.007697:0.002437:0.006632:0.007684:0.002437:0.005157:0.006632:0.002437:0.007684:0.005311:0.005311:0.002437:0.004015:0.002437:0.006632:0.007684:0.003951:0.002437:0.007774:0.006825:0.002412:0.004513:0.008467:0.005157:0.006440:0.006902:0.004900:0.008736:0.006607:0.003566:0.007774:0.005311:0.003566:0.007684:0.003951:0.002437:0.006632:0.005157:0.007684:0.007697:0.007068:0.006825:0.003951:0.005311:0.002412
S4 ONCOGEM 200 (Powder for injection). Each vial contains 227,6 mg gemcitabine hydrochloride equivalent to 200 mg of gemcitabine free base. :@1.073949:0.821621:1.925905:0.821621:1.925905:0.810402:1.073949:0.810402:0.006927:0.007325:0.004900:0.010519:0.009634:0.009121:0.010519:0.009493:0.007043:0.011019:0.005157:0.006440:0.007107:0.007107:0.005285:0.003772:0.006966:0.007388:0.009249:0.007697:0.007068:0.004054:0.005093:0.003630:0.007774:0.004054:0.005285:0.002437:0.006825:0.002412:0.007068:0.006632:0.003951:0.002437:0.007774:0.006440:0.003387:0.002412:0.005285:0.006786:0.007684:0.006632:0.006722:0.004899:0.006568:0.002437:0.007684:0.002437:0.005157:0.006632:0.007774:0.006825:0.003566:0.007684:0.002437:0.006825:0.005181:0.005157:0.006440:0.006183:0.005747:0.002463:0.006902:0.005285:0.010288:0.007697:0.005157:0.007697:0.007068:0.010288:0.006632:0.002437:0.003565:0.007684:0.007697:0.002437:0.006825:0.007068:0.005285:0.006337:0.006414:0.007697:0.004052:0.007774:0.006632:0.006722:0.002437:0.007774:0.004631:0.002437:0.007697:0.007068:0.005285:0.007068:0.007697:0.006735:0.002437:0.006312:0.007684:0.002437:0.007068:0.006825:0.003759:0.005157:0.003566:0.007646:0.005157:0.006440:0.007107:0.007107:0.005285:0.010288:0.007697:0.005157:0.007582:0.003823:0.005157:0.007697:0.007068:0.010288:0.006632:0.002437:0.003566:0.007684:0.007697:0.002437:0.006825:0.007068:0.005093:0.004015:0.004052:0.007068:0.007068:0.005285:0.007697:0.007684:0.005311:0.006812:0.002412:0.005285
Reg. No.: 43/26/1171. Pharmacological classification: A 26 Cytostatic agents.:@1.073949:0.832222:1.509171:0.832222:1.509171:0.821003:1.073949:0.821003:0.007453:0.007068:0.007697:0.002412:0.005285:0.009634:0.007389:0.002412:0.002412:0.005285:0.007325:0.006940:0.005029:0.006440:0.006966:0.005414:0.003861:0.003861:0.007030:0.003861:0.002412:0.005285:0.007351:0.006722:0.007684:0.004631:0.010288:0.007684:0.006632:0.007774:0.002437:0.007774:0.007697:0.002437:0.006632:0.007684:0.002437:0.005157:0.006632:0.002437:0.007684:0.005311:0.005311:0.002437:0.004015:0.002437:0.006632:0.007684:0.003951:0.002437:0.007774:0.006825:0.002412:0.004514:0.008465:0.005158:0.006440:0.006902:0.004900:0.008736:0.006607:0.003565:0.007774:0.005311:0.003566:0.007684:0.003951:0.002437:0.006632:0.005157:0.007684:0.007697:0.007068:0.006825:0.003951:0.005311:0.002412
S4 CIPLA-VINORELBINE 10 / 50 (Intravenous injection). Each single dose vial contains 13,85 mg / 69,25 mg of vinorelbine tartrate which is :@1.073949:0.842823:1.877102:0.842823:1.877102:0.831604:1.073949:0.831604:0.006927:0.007325:0.004900:0.009121:0.003464:0.007351:0.006106:0.008595:0.004155:0.009095:0.003464:0.009634:0.010519:0.007774:0.007043:0.006363:0.007594:0.003464:0.009634:0.007043:0.004965:0.003861:0.007107:0.004514:0.004900:0.004965:0.007120:0.007107:0.005285:0.003772:0.003464:0.006825:0.003951:0.004054:0.007684:0.006183:0.007068:0.006825:0.007774:0.006735:0.005181:0.005285:0.002437:0.006825:0.002412:0.007068:0.006632:0.003951:0.002437:0.007774:0.006440:0.003385:0.002412:0.005285:0.006786:0.007684:0.006632:0.006722:0.005285:0.005311:0.002437:0.006825:0.007697:0.002437:0.007068:0.005156:0.007697:0.007774:0.005311:0.007068:0.004900:0.006568:0.002437:0.007684:0.002437:0.005157:0.006632:0.007774:0.006825:0.003566:0.007684:0.002437:0.006825:0.005184:0.004963:0.003861:0.007068:0.002463:0.006953:0.006993:0.005285:0.010288:0.007697:0.004514:0.004899:0.004966:0.006837:0.006440:0.002463:0.006440:0.006991:0.005285:0.010288:0.007697:0.005156:0.007582:0.003823:0.004900:0.006568:0.002437:0.006825:0.007774:0.004054:0.007068:0.002437:0.007697:0.002437:0.006825:0.007068:0.005156:0.003566:0.007684:0.004631:0.003951:0.004054:0.007684:0.003566:0.007068:0.005220:0.009570:0.006722:0.002437:0.006632:0.006722:0.005285:0.002437:0.005181:0.005285
equivalent to 10 mg / 50 mg of vinorelbine base per millilitre / 5 millilitres of solution. Reg. No.: 42/26/0083, 84. :@1.073949:0.853423:1.721584:0.853423:1.721584:0.842205:1.073949:0.842205:0.007068:0.007697:0.006735:0.002437:0.006312:0.007684:0.002437:0.007068:0.006825:0.003757:0.005157:0.003566:0.007646:0.004965:0.003861:0.007107:0.005285:0.010288:0.007697:0.004516:0.004900:0.004965:0.007120:0.007107:0.005285:0.010288:0.007697:0.005156:0.007582:0.003823:0.004900:0.006568:0.002437:0.006825:0.007774:0.004052:0.007068:0.002437:0.007697:0.002437:0.006825:0.007068:0.005285:0.007697:0.007684:0.005311:0.007068:0.005285:0.007697:0.007068:0.004052:0.005285:0.010288:0.002437:0.002437:0.002437:0.002437:0.002437:0.002437:0.003951:0.004052:0.007068:0.004516:0.004900:0.004965:0.006991:0.005285:0.010288:0.002437:0.002437:0.002437:0.002437:0.002437:0.002437:0.003951:0.004052:0.007068:0.005183:0.005156:0.007582:0.003823:0.005285:0.005311:0.007774:0.002437:0.006735:0.003951:0.002437:0.007774:0.006825:0.002412:0.005285:0.007452:0.007068:0.007697:0.002412:0.005285:0.009634:0.007387:0.002412:0.002412:0.005285:0.007325:0.006440:0.005030:0.006440:0.006966:0.005284:0.007107:0.007107:0.006953:0.007068:0.002463:0.005285:0.006953:0.007325:0.002412:0.005285
Pharmacological classification: A 26 Cytostatic agents.:@1.073949:0.864024:1.387700:0.864024:1.387700:0.852806:1.073949:0.852806:0.007351:0.006722:0.007684:0.004631:0.010288:0.007684:0.006632:0.007774:0.002437:0.007774:0.007697:0.002437:0.006632:0.007684:0.002437:0.005157:0.006632:0.002437:0.007684:0.005311:0.005311:0.002437:0.004015:0.002437:0.006632:0.007684:0.003951:0.002437:0.007774:0.006825:0.002412:0.004513:0.008467:0.005157:0.006440:0.006902:0.004900:0.008736:0.006607:0.003566:0.007774:0.005311:0.003566:0.007684:0.003951:0.002437:0.006632:0.005157:0.007684:0.007697:0.007068:0.006825:0.003951:0.005311:0.002412
S4 CARBOSIN 150 / 450 / 600. Each vial contains 150 mg / 450 mg / 600 mg carboplatin (10 mg/ml). Reg. No.: Z/26/261, 62, A39/26/0170. :@1.073949:0.874625:1.882411:0.874625:1.882411:0.863407:1.073949:0.863407:0.006927:0.007325:0.004900:0.009121:0.009236:0.007774:0.007594:0.010519:0.007056:0.003464:0.009634:0.004963:0.003861:0.007120:0.007107:0.004516:0.004900:0.005285:0.007197:0.007120:0.007107:0.004514:0.004900:0.004965:0.007222:0.007107:0.006722:0.002412:0.005285:0.006786:0.007684:0.006632:0.006722:0.004899:0.006568:0.002437:0.007684:0.002437:0.005157:0.006632:0.007774:0.006825:0.003566:0.007684:0.002437:0.006825:0.005183:0.004963:0.003861:0.007120:0.007107:0.005285:0.010288:0.007697:0.004516:0.004900:0.005285:0.007197:0.007120:0.007107:0.005285:0.010288:0.007697:0.004514:0.004900:0.004965:0.007222:0.007107:0.007107:0.005285:0.010288:0.007697:0.005156:0.006632:0.007684:0.004631:0.007697:0.007774:0.007697:0.002437:0.007684:0.003951:0.002437:0.006825:0.005285:0.004154:0.003861:0.007107:0.005285:0.010288:0.007697:0.004900:0.010288:0.002437:0.003385:0.002412:0.005285:0.007453:0.007068:0.007697:0.002412:0.005285:0.009634:0.007389:0.002412:0.002412:0.004578:0.008082:0.005029:0.006440:0.006966:0.005029:0.006440:0.006837:0.003861:0.002463:0.004965:0.007030:0.006440:0.002463:0.004514:0.009236:0.006812:0.006183:0.005029:0.006440:0.006966:0.005285:0.007107:0.003861:0.006645:0.006722:0.002412:0.005285
Pharmacological classification: A 26 Cytostatic agents.:@1.073949:0.885226:1.387700:0.885226:1.387700:0.874008:1.073949:0.874008:0.007351:0.006722:0.007684:0.004631:0.010288:0.007684:0.006632:0.007774:0.002437:0.007774:0.007697:0.002437:0.006632:0.007684:0.002437:0.005157:0.006632:0.002437:0.007684:0.005311:0.005311:0.002437:0.004015:0.002437:0.006632:0.007684:0.003951:0.002437:0.007774:0.006825:0.002412:0.004513:0.008467:0.005157:0.006440:0.006902:0.004900:0.008736:0.006607:0.003566:0.007774:0.005311:0.003566:0.007684:0.003951:0.002437:0.006632:0.005157:0.007684:0.007697:0.007068:0.006825:0.003951:0.005311:0.002412
S4 VINBLASTINE TEVA 10. Each vial contains vinblastine sulphate 1 mg/ml. Reg. No.: 45/26/0373. :@1.073949:0.895827:1.636346:0.895827:1.636346:0.884609:1.073949:0.884609:0.006927:0.007325:0.004516:0.009095:0.003464:0.009634:0.007594:0.006106:0.008980:0.006669:0.006645:0.003464:0.009634:0.007043:0.004259:0.006645:0.006979:0.007684:0.008467:0.004965:0.003861:0.006722:0.002412:0.005285:0.006786:0.007684:0.006632:0.006722:0.004899:0.006568:0.002437:0.007684:0.002437:0.005157:0.006632:0.007774:0.006825:0.003566:0.007684:0.002437:0.006825:0.005183:0.004900:0.006568:0.002437:0.006825:0.007697:0.002437:0.007684:0.005311:0.003951:0.002437:0.006825:0.007068:0.005285:0.005311:0.006735:0.002437:0.007697:0.006722:0.007684:0.003564:0.007068:0.004965:0.003861:0.005285:0.010288:0.007697:0.004899:0.010288:0.002437:0.002412:0.005285:0.007455:0.007068:0.007697:0.002412:0.005285:0.009634:0.007388:0.002412:0.002412:0.005285:0.007197:0.006863:0.005029:0.006440:0.006966:0.005285:0.007107:0.006812:0.006645:0.006940:0.002412:0.005285
Pharmacological classification: A 26 Cytostatic agents.:@1.073949:0.906428:1.387700:0.906428:1.387700:0.895210:1.073949:0.895210:0.007351:0.006722:0.007684:0.004631:0.010288:0.007684:0.006632:0.007774:0.002437:0.007774:0.007697:0.002437:0.006632:0.007684:0.002437:0.005157:0.006632:0.002437:0.007684:0.005311:0.005311:0.002437:0.004015:0.002437:0.006632:0.007684:0.003951:0.002437:0.007774:0.006825:0.002412:0.004513:0.008467:0.005157:0.006440:0.006902:0.004900:0.008736:0.006607:0.003566:0.007774:0.005311:0.003566:0.007684:0.003951:0.002437:0.006632:0.005157:0.007684:0.007697:0.007068:0.006825:0.003951:0.005311:0.002412
Lung Cancer:@1.231891:0.533962:1.647968:0.533962:1.647968:0.471021:1.231891:0.471021:0.034619:0.037786:0.038290:0.043184:0.027494:0.050453:0.043112:0.038290:0.037210:0.039657:0.025982
TEVA PHARMACEUTICALS (PTY) LTD. Co. Reg. No. 1986/002796/07. Maxwell Office Park, Magwa Crescent West, Waterfall City, Midrand, 2090. :@1.073949:0.934322:1.907106:0.934322:1.907106:0.923104:1.073949:0.923104:0.006645:0.006979:0.007684:0.008467:0.005285:0.007351:0.009326:0.009236:0.007774:0.011019:0.008722:0.009121:0.007043:0.008928:0.006645:0.003464:0.009121:0.009236:0.006235:0.006863:0.005285:0.003772:0.007157:0.006645:0.007979:0.003772:0.005285:0.005401:0.006645:0.008544:0.002412:0.004902:0.008991:0.007389:0.002412:0.005285:0.007452:0.007068:0.007697:0.002412:0.005285:0.009634:0.007389:0.002412:0.004963:0.003861:0.007081:0.006953:0.006966:0.005285:0.007107:0.007107:0.006183:0.006645:0.006696:0.006966:0.005285:0.006850:0.005811:0.002412:0.005285:0.011019:0.007684:0.006581:0.009248:0.007068:0.002437:0.002437:0.004900:0.010519:0.004015:0.004015:0.002437:0.006632:0.007068:0.005285:0.006964:0.007684:0.004631:0.006235:0.002463:0.005285:0.011019:0.007684:0.007697:0.009248:0.007684:0.004900:0.009121:0.004054:0.007068:0.005311:0.006632:0.007068:0.006825:0.003759:0.004708:0.011161:0.007068:0.005311:0.003374:0.002463:0.004708:0.010904:0.007684:0.003566:0.007068:0.004631:0.003629:0.007684:0.002437:0.002437:0.004900:0.009121:0.002437:0.003951:0.005580:0.002463:0.005285:0.011019:0.002437:0.007697:0.004052:0.007684:0.006825:0.007697:0.002463:0.005157:0.006440:0.007107:0.007081:0.006721:0.002412:0.005285
Tel: +27 11 055 0200, Fax: +27 86 680 8988. Marketed by CIPLA MEDPRO (PTY) LTD. Co. Reg. No. 1995/004182/07. Building 9, Parc du Cap, :@1.073949:0.945091:1.879977:0.945091:1.879977:0.933872:1.073949:0.933872:0.005747:0.007068:0.002437:0.002412:0.005285:0.004540:0.006185:0.006388:0.004963:0.003861:0.003861:0.005285:0.007107:0.007120:0.006991:0.005285:0.007107:0.006440:0.007107:0.007107:0.002463:0.005285:0.006169:0.007684:0.006196:0.002412:0.005285:0.004541:0.006183:0.006388:0.005285:0.006953:0.006902:0.004963:0.007222:0.006953:0.007107:0.005285:0.006698:0.007081:0.006953:0.006504:0.002412:0.005285:0.011019:0.007684:0.004631:0.005592:0.007068:0.003566:0.007068:0.007697:0.005285:0.007312:0.006286:0.004900:0.009121:0.003464:0.007351:0.006106:0.008467:0.005285:0.011019:0.007043:0.009313:0.007351:0.007774:0.010133:0.005285:0.003772:0.007158:0.006645:0.007979:0.003772:0.005285:0.005399:0.006645:0.008544:0.002412:0.004900:0.008993:0.007389:0.002412:0.005285:0.007453:0.007068:0.007697:0.002412:0.005285:0.009634:0.007388:0.002412:0.004965:0.003861:0.007081:0.006825:0.006863:0.005285:0.007107:0.007107:0.007325:0.003861:0.006695:0.006440:0.005285:0.006850:0.005811:0.002412:0.005285:0.007594:0.006735:0.002437:0.002437:0.007697:0.002437:0.006825:0.007697:0.005027:0.006440:0.002463:0.005285:0.006967:0.007684:0.004052:0.006632:0.005157:0.007697:0.006735:0.004899:0.008993:0.007684:0.007378:0.002463:0.005285
Mispel Street, Bellville, 7530, RSA. Website: www.cipla.co.za Customer Care: 080 222 6662. [13129] [26/ONC/2017]:@1.073949:0.955859:1.723150:0.955859:1.723150:0.944641:1.073949:0.944641:0.011019:0.002437:0.005311:0.007697:0.007068:0.002437:0.005092:0.007056:0.003951:0.004054:0.007068:0.007068:0.003374:0.002463:0.005285:0.007594:0.007068:0.002437:0.002437:0.006568:0.002437:0.002437:0.002437:0.007068:0.002463:0.004835:0.006260:0.007120:0.007197:0.007107:0.002463:0.005285:0.007774:0.006798:0.009236:0.002412:0.004708:0.011161:0.007068:0.007697:0.005311:0.002437:0.003565:0.007068:0.002412:0.005221:0.009570:0.009570:0.008672:0.002027:0.006632:0.002437:0.007697:0.002437:0.007684:0.002026:0.006632:0.007389:0.002412:0.005952:0.007684:0.004900:0.009121:0.006735:0.005311:0.003566:0.007774:0.010288:0.007068:0.004052:0.004900:0.008993:0.007684:0.004054:0.007068:0.002412:0.005285:0.007107:0.006953:0.007107:0.005156:0.006440:0.006440:0.006440:0.004965:0.007222:0.007222:0.007030:0.006440:0.002412:0.005285:0.004323:0.003861:0.007197:0.003861:0.006440:0.007081:0.003938:0.005285:0.003938:0.006440:0.006963:0.005030:0.010519:0.009634:0.009057:0.005029:0.006440:0.007107:0.003861:0.007542:0.003938